SEC Tracker
Get the app

Possible new RxSight shares

RXSTDilution

Known so far: no new shares from the prospectus covers read · shelf not limited by the baby-shelf rule · not yet read: warrants, converts, ATM.

Shelf room

  • Room today not capped by the baby-shelf rule ($504M float, Jun 30, 2025)
How this is worked out

Shelf room on the S-3ASR of May 8, 2024: not limited by the baby-shelf rule, because the $504M public float stated as of Jun 30, 2025 is $75M or more. Sources: S-3ASR May 8, 2024, effective May 8, 2024 · public float, as of Jun 30, 2025.

What could become new RxSight (RXST) shares: options and RSUs, each with the 10-Q, 10-K, S-3 or 424B filing it comes from.

RxSight dilution ladder

Every source of new shares on record, from the filings that created it.

41.9M outstanding; up to 45M fully diluted, +7%

  1. Outstandingas of Oct 30, 2026 (10-Q filed Nov 3) · share count on the cover page
    41.9M
  2. Options and RSUs66K options, 3M RSUs10-Q Nov 3, 2026 · securities left out of diluted EPS
    +3M

Not stated in the filings we read: an ATM program, warrants, convertible notes.

Counts, sizes and prices as stated in each filing; the fully diluted count is arithmetic on them. Dollars become shares only at a price a filing states. Not advice.

Shares outstanding

41.9M

Feb 2025 to Oct 2026: from 40.5M to 41.9M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.